Articles by Disease (Sarcoma)

Cancer Resistance to Type II Topoisomerase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 19
Page: 3900-3906
Author(s): P. Pilati, D. Nitti and S. Mocellin

Strategies to Improve the Killing of Tumors Using Temozolomide: Targeting the DNA Repair Protein MGMT

Journal: Current Medicinal Chemistry
Volume: 19
Page: 3886-3892
Author(s): G. Jiang, L. -T. Li, Y. Xin, L. Zhang, Y. -Q. Liu and J. -N. Zheng

Role of PARP Inhibitors in Cancer Biology and Therapy

Journal: Current Medicinal Chemistry
Volume: 19
Page: 3907-3921
Author(s): D. Davar, J. H. Beumer, L. Hamieh and H. Tawbi

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18
Page: 3816-3827
Author(s): Eveline M. Dijkgraaf, Marij J.P. Welters, Johan W.R. Nortier, Sjoerd H. van der Burg and Judith R. Kroep

Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18
Page: 3754-3769
Author(s): Bradley J. Monk, Heather Dalton, Ivor Benjamin and Adnan Tanovic

The Role of Pericytes in Blood-Brain Barrier Function and Stroke

Journal: Current Pharmaceutical Design
Volume: 18
Page: 3653-3662
Author(s): Shuo Liu, Dritan Agalliu, Chuanhui Yu and Mark Fisher

Malignancy in Common Variable Immune Deficiency: Report of Two Rare Cases of Gastrointestinal Malignancy and a Review of the Literature

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12
Page: 21-27
Author(s): Casey Watkins, Ryan Sahni, Nikhil Holla, John Litchfield, George Youngberg and Guha Krishnaswamy